Reporting owner · CIK 0002079673

Wong Ryan Ho-Yan

Visual SEC Form 4 history across 1 companies, 1 transactions and 1 filings.

CFOChief Financial OfficerSarepta Therapeutics, Inc.
Open-market mix
Filings1Form 4 records
Buying$00 purchases
Selling$00 sales
Net value$0Buys minus sells
Companies11 securities
Most recentSep 04, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
No open-market purchases or sales in this history.

Net value flow

Buys minus sells

Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size
Median P/S size
Direct1
Indirect0
Sep 04, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

No filing-only signal badges matched this history.

Latest Form 4 facts

Quick context from source filings

Latest transaction

No latest transaction fact is available.

Latest buy

No open-market insider purchase is available.

Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
SRPTWong Ryan Ho-Yan
CFO
withholding13.2k-$29.4MF0.0%09/0909/04

Wong Ryan Ho-Yan Insider Activity FAQ

SEC Form 4 context

Who is Wong Ryan Ho-Yan?

Wong Ryan Ho-Yan is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002079673.

Which companies has Wong Ryan Ho-Yan reported transactions for?

Sarepta Therapeutics, Inc.

When was Wong Ryan Ho-Yan's latest insider buy?

No open-market insider purchase is available for this period.

When was Wong Ryan Ho-Yan's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.